Coleman, Craig I.

Understanding heterogeneity in meta-analysis: the role of meta-regression

Baker, W. L., Michael White, C., Cappelleri, J. C., Kluger, J., Coleman, C. I., & From the Health Outcomes, P. (2009) · International Journal of Clinical Practice

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 492

Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis

Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013) · The Annals of Family Medicine

Natural Antidiabetic Agents StudiesNatural Products and Biological Research

Cited by 269

Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism

Lefebvre, P., Coleman, C. I., Bookhart, B. K., Wang, S.-T., Mody, S. H., Tran, K. N., Zhuo, D. Y., Huynh, L., & Nutescu, E. A. (2014) · Journal of Medical Economics

Venous Thromboembolism Diagnosis and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 66

Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis

Kaw, R., Pasupuleti, V., Wayne Overby, D., Deshpande, A., Coleman, C. I., Ioannidis, J. P. A., & Hernandez, A. V. (2014) · Surgery for Obesity and Related Diseases

Venous Thromboembolism Diagnosis and ManagementBariatric Surgery and Outcomes

Cited by 47

Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis

Sobieraj, D. M., Coleman, C. I., Pasupuleti, V., Deshpande, A., Kaw, R., & Hernandez, A. V. (2015) · Thrombosis Research

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes

Cited by 42

Cost-effectiveness analysis of extended duration anticoagulation with rivaroxaban to prevent recurrent venous thromboembolism

Coleman, C. I., Limone, B. L., Bookhart, B. K., Mody, S. H., & Nutescu, E. A. (2014) · Thrombosis Research

Venous Thromboembolism Diagnosis and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 18

Rivaroxaban versus heparin bridging to warfarin therapy: impact on hospital length of stay and treatment costs for low-risk patients with pulmonary embolism

Weeda, E. R., Kohn, C. G., Peacock, W. F., Fermann, G. J., Crivera, C., Schein, J. R., & Coleman, C. I. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes

Cited by 15

Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients

Coleman, C. I., Pandya, S., Wang, L., Baser, O., Cai, J., Ingham, M., & Bookhart, B. (2019) · Journal of Comparative Effectiveness Research

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 10